This invention uses our knowledge of the mechanisms by which antigen is
recognized by T cells to identify and prepare human papillomavirus (HPV)
epitopes, and to develop epitope-based vaccines directed towards HPV.
More specifically, this application communicates our discovery of
pharmaceutical compositions and methods of use in the prevention and
treatment of HPV infection.